University of Sheffield research gives new hope to cancer patients

Have your say

University of Sheffield research has found that a generic drug can improve breast cancer survival prospects in post-menopausal women.

Results of the study, led by Professor Robert Coleman from the University’s Department of Oncology, have been published in The Lancet.

It found that treatment with a class of drugs called bisphosphonates, which are usually used to treat osteoporosis, reduces the risk of breast cancer recurring in post-menopausal women.

Professor Coleman said: “These simple, well tolerated treatments should now be considered for routine use in the treatment of early breast cancer in women with either a natural or medically induced menopause to extend survival and reduce the adverse effects of cancer treatments.”